NCF DIAGNOSTICS & DNA TECHNOLOGIES Trademark

Trademark Overview

On Friday, August 31, 2018, a trademark application was filed for NCF DIAGNOSTICS & DNA TECHNOLOGIES with the United States Patent and Trademark Office. The USPTO has given the NCF DIAGNOSTICS & DNA TECHNOLOGIES trademark a serial number of 88100376. The federal status of this trademark filing is REGISTERED as of Tuesday, July 2, 2019. This trademark is owned by North Central Florida Neurodiagnostic Limited Liability Company. The NCF DIAGNOSTICS & DNA TECHNOLOGIES trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Providing laboratory research services in the field of gene expression, namely, cancer biology
ncf diagnostics & dna technologies

General Information

Serial Number88100376
Word MarkNCF DIAGNOSTICS & DNA TECHNOLOGIES
Filing DateFriday, August 31, 2018
Status700 - REGISTERED
Status DateTuesday, July 2, 2019
Registration Number5792190
Registration DateTuesday, July 2, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 16, 2019

Trademark Statements

Pseudo MarkNORTH CENTRAL FLORIDA DIAGNOSTICS AND DNA TECHNOLOGIES
NOT AVAILABLE"DIAGNOSTICS & DNA TECHNOLOGIES"
Goods and ServicesConsulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Providing laboratory research services in the field of gene expression, namely, cancer biology

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, September 10, 2018
Primary Code042
First Use Anywhere DateThursday, March 2, 2017
First Use In Commerce DateThursday, March 2, 2017

Trademark Owner History

Party NameNorth Central Florida Neurodiagnostic Limited Liability Company
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressAlachua, FL 32615
Party NameNorth Central Florida Neurodiagnostic Limited Liability Company
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressAlachua, FL 32615
Party NameNorth Central Florida Neurodiagnostic Limited Liability Company
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressAlachua, FL 32615

Trademark Events

Event DateEvent Description
Tuesday, September 4, 2018NEW APPLICATION ENTERED
Monday, September 10, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 14, 2018EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Thursday, December 13, 2018ASSIGNED TO EXAMINER
Friday, December 14, 2018EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Friday, December 14, 2018COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Friday, December 14, 2018NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Monday, December 17, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 17, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 17, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 2, 2019FINAL REFUSAL WRITTEN
Wednesday, January 2, 2019FINAL REFUSAL E-MAILED
Wednesday, January 2, 2019NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, January 28, 2019TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, February 1, 2019ASSIGNED TO LIE
Friday, February 1, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 1, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 1, 2019EXAMINERS AMENDMENT -WRITTEN
Friday, February 1, 2019EXAMINERS AMENDMENT E-MAILED
Friday, February 1, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, February 1, 2019EXAMINER'S AMENDMENT ENTERED
Friday, February 1, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 6, 2019TEAS POST PUBLICATION AMENDMENT RECEIVED
Friday, March 1, 2019CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Tuesday, February 5, 2019TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, February 19, 2019WITHDRAWN FROM PUB - OG REVIEW QUERY
Wednesday, February 27, 2019ASSIGNED TO PETITION STAFF
Monday, March 4, 2019PREVIOUS ALLOWANCE COUNT WITHDRAWN
Wednesday, March 13, 2019NON-FINAL ACTION E-MAILED
Wednesday, March 13, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 13, 2019NON-FINAL ACTION WRITTEN
Thursday, March 14, 2019EXAMINERS AMENDMENT -WRITTEN
Thursday, March 14, 2019EXAMINERS AMENDMENT E-MAILED
Thursday, March 14, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, March 14, 2019EXAMINER'S AMENDMENT ENTERED
Thursday, March 14, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 14, 2019LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, March 27, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 16, 2019PUBLISHED FOR OPPOSITION
Tuesday, April 16, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 2, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, July 2, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

technologies diagnostics research services laboratory field expression gene namely biology cancer providing